INTRODUCTION
============

Endoscopic retrograde cholangiopancreatography (ERCP) with standard brush cytology and/or forceps biopsy was one of the first approaches in the evaluation of obstructive biliary and pancreatic duct diseases. However, ERCP does not provide an intraluminal view of the pancreaticobiliary pathology. Cholangiopancreatoscopy overcomes this limitation by allowing direct visualization of the biliary and pancreatic ducts. The first cholangioscope was described in 1941, and the peroral approach was subsequently introduced in the early 1970s \[[@b1-ce-2019-011],[@b2-ce-2019-011]\]. The early cholangioscopy system, known as the mother-daughter system, consisted of a mother duodenoscope and a daughter cholangiopancreatoscope. The limitations of this system were the need for two operators, scope fragility, and poor image quality. Over the past decade, there have been significant improvements in cholangioscopy technology. These include improved image quality, easy setup, need for only one operator, and ability to perform targeted biopsies and therapeutic procedures, such as lithotripsy. One of the main indications for cholangioscopy is the evaluation of biliary strictures when imaging, and ERCP with brush cytology and/or biopsy does not yield a definitive diagnosis. These indeterminate biliary strictures present a diagnostic challenge for endoscopists as both malignant and benign etiologies should be considered. Cholangioscopy offers the advantage of direct visualization of the biliary epithelium to assess malignant features and targeted biopsy results of suspected lesions. This review summarizes the role of peroral cholangioscopy in the evaluation of indeterminate biliary strictures.

PERORAL CHOLANGIOSCOPY
======================

Cholangioscopy can be performed perorally or percutaneously. The peroral approach can be performed using an ultraslim endoscope (direct peroral cholangioscopy system \[DPCS\], GIF-XP; Olympus Co., Tokyo, Japan) or a catheter-based system with a single-operator cholangiopancreatoscope (SOCP, SpyGlass Direct Visualization System; Boston Scientific Endoscopy, Marlboro, MA, USA). [Table 1](#t1-ce-2019-011){ref-type="table"} summarizes the features, advantages, and disadvantages of the different cholangioscopy systems.

In the DPCS, an ultraslim gastroscope is advanced in a monorail fashion over a guidewire or with balloon assistance into the biliary tree. This approach requires sphincterotomy or distal duct dilation for advancement of the cholangioscope through the biliary sphincter. The DPCS allows targeted biopsy of mucosal abnormalities or direct treatment of stone diseases. This system has a high-definition video technology with a superior image quality compared with the SOCP. Additional complementary imaging modalities, such as narrow band imaging (NBI) and probe-based confocal laser endomicroscopy (pCLE), can be used to improve the diagnostic yield further. NBI allows enhanced visualization of superficial mucosal capillary and pit patterns and thicker capillaries of the deeper tissues by restricting light to two waveforms (i.e., 415 and 540 nm). pCLE provides histologic-level images by passing a laser light through a confocal aperture. Owing to the required expertise and high cost, the use of this technique is currently only limited to select centers.

In 2007, the first-generation SOCP was introduced to clinical practice. This device was a single-use fibro-optic-based device (fibro-optic SOCP \[FSOCP\]) that allowed a single operator to complete the procedure. A new digital version of the SOCP (SpyGlass DS, SPY DS; digital SOCP \[DSOCP\]) has several advantages compared with the fibro-optic-based device. The new system consists of a sterile, single-use SpyScope access and delivery catheter, SpyGlass digital controller, and SpyBite, which is a biliary biopsy forcep. This system utilizes two light-emitting diodes that improve the image quality and provides a wider endoscopic field of view. Further, there is a dedicated aspiration and irrigation channel, and the tapered tip enables a less traumatic advancement across the papilla and strictures.

CLINICAL INDICATIONS AND CONTRAINDICATIONS
==========================================

Peroral cholangioscopy can be utilized for both diagnostic indications and therapeutic applications. [Table 2](#t2-ce-2019-011){ref-type="table"} summarizes the key clinical indications and contraindications for performing cholangioscopy. The two most common indications for peroral cholangioscopy are management of complex bile duct stones and assessment of indeterminate biliary strictures \[[@b3-ce-2019-011],[@b4-ce-2019-011]\].

INDETERMINATE BILIARY STRICTURES
================================

Biliary strictures are considered indeterminate when the initial radiologic evaluation and ERCP with standard brush cytology and/or forceps biopsy do not yield a definitive diagnosis. These strictures can be benign or malignant and can originate from the intra- or extrahepatic biliary tree, pancreas, liver, gallbladder, ampulla, regional lymph nodes, or invasion from other gastrointestinal malignancies and metastases. Evaluation of these strictures is of paramount importance, as early diagnosis avoids unnecessary surgical procedures and yields optimal patient outcomes. [Table 3](#t3-ce-2019-011){ref-type="table"} summarizes the differential diagnosis for benign and malignant biliary strictures. The leading causes of malignant biliary strictures are cholangiocarcinoma and pancreatic cancer \[[@b5-ce-2019-011]\].

The diagnosis of malignant biliary strictures can be predicted on the basis of cholangioscopic visual characteristics. However, tissue acquisition is required for the final diagnosis and can be performed via ERCP with standard brush cytology and/or forceps biopsy, endoscopic ultrasound-guided fine needle aspiration (EUS-FNA), and cholangioscopy-guided forceps biopsy. ERCP with standard brush cytology and/or forceps biopsy is often the first diagnostic approach employed. However, this is limited by its low sensitivity and high rates of false-negative results. In a systematic review and meta-analysis (nine studies; 730 patients) on the effectiveness of ERCP for detecting malignant biliary strictures, the pooled sensitivities of brushing cytology and forceps biopsy were 45% and 48.1%, respectively. The combination of the two methods increased the sensitivity only to 59.4% \[[@b6-ce-2019-011]\]. In patients with biliary strictures due to extrinsic compression (e.g., pancreatic tumors or regional lymph nodes), EUS-FNA has a high diagnostic value and should be considered the standard of care \[[@b7-ce-2019-011]\]. A recent meta-analysis on the diagnostic yield of EUS-FNA (41 studies; 4,766 patients) reported a pooled sensitivity and specificity of 86.8% and 95.8%, respectively, for diagnosing solid pancreatic masses \[[@b8-ce-2019-011]\]. The limitations of EUS are challenges in accessing proximal biliary strictures and concerns on seeding malignancy along the FNA tract \[[@b9-ce-2019-011],[@b10-ce-2019-011]\].

CHOLANGIOSCOPY FOR VISUAL ASSESSMENT OF THE BILIARY EPITHELIUM
==============================================================

[Table 4](#t4-ce-2019-011){ref-type="table"} summarizes the biliary epithelial visual findings during cholangioscopy. Seo et al. and Fukuda et al. were the first to illustrate these findings and described malignant strictures as lesions with irregularly dilated and tortuous vessels (tumor vessels), nodularity, papillary characteristics, neovascularization, easy oozing, and irregular surface \[[@b11-ce-2019-011],[@b12-ce-2019-011]\]. Conversely, benign strictures have smooth mucosa, borders without neovascularization, and papillo-granular mucosa with no obvious mass \[[@b11-ce-2019-011],[@b12-ce-2019-011]\]. The strongest feature suggestive of malignancy is the presence of dilated and tortuous vessels, with a reported positive predictive value of up to 100% \[[@b13-ce-2019-011]\].

[Table 5](#t5-ce-2019-011){ref-type="table"} summarizes the performance of the DPCS in the diagnosis of malignant biliary strictures. The reported sensitivity and specificity of DPCS visual impression for the diagnosis of malignancy are 83%--92% and 84%--92%, respectively \[[@b14-ce-2019-011]-[@b16-ce-2019-011]\]. In the first US report on the operating characteristics of the DPCS in 96 patients with indeterminate biliary strictures, the sensitivity and specificity were 85% and 84%, respectively \[[@b14-ce-2019-011]\]. In a feasibility study on the DPCS with the addition of NBI compared with the use of high-definition white light, Itoi et al. reported an improved visualization of both the surface structures and vessels with the use of NBI \[[@b17-ce-2019-011]\]. They also reported the detection of four out of 21 lesions on NBI that were not seen with the use of high-definition white light \[[@b17-ce-2019-011]\].

[Table 6](#t6-ce-2019-011){ref-type="table"} summarizes the data on the diagnostic yield of SOCP visual impression for indeterminate biliary strictures \[[@b18-ce-2019-011]-[@b34-ce-2019-011]\]. The reported sensitivity, specificity, and accuracy ranged from 78% to 100%, from 77% to 97.6%, and from 80% to 97%, respectively ([Table 7](#t7-ce-2019-011){ref-type="table"}) \[[@b6-ce-2019-011],[@b9-ce-2019-011],[@b14-ce-2019-011],[@b35-ce-2019-011]-[@b37-ce-2019-011]\]. In the report by Chen at al. (226 patients from 15 centers), FSOCP visual impression was found to be more sensitive and specific than ERCP fluoroscopic impression for diagnosing malignant biliary strictures (sensitivity, 78% vs. 51%; specificity, 82% vs. 54%, respectively). This study also found a higher sensitivity for strictures caused by intrinsic lesions than for those caused by extrinsic lesions (84% vs. 61%, respectively) \[[@b19-ce-2019-011]\]. In a systematic review and meta-analysis on the diagnostic yield of the FSOCP based on visual impression (a total of six studies; 456 patients), the pooled sensitivity and specificity for diagnosing malignant biliary strictures were 84.5% and 82.6%, respectively \[[@b38-ce-2019-011]\].

The visual diagnostic yield of the second-generation DSOCP (SPY DS) is reported to be higher than that of the first-generation FSOCP. In a multicenter study (two centers; 44 patients), the sensitivity and specificity of DSOCP visual impression for the diagnosis of malignant biliary strictures were 90% and 95.8%, respectively \[[@b34-ce-2019-011]\]. In another similar study, the sensitivity and specificity of DSOCP visual impression were 95.5% and 94.5%, respectively \[[@b26-ce-2019-011]\]. Recently, Mizrahi et al. compared the diagnostic yield of visual impression between the FSOCP and DSOCP for malignant biliary strictures (324 patients; FSOCP, 198 and DSOCP, 126) and reported a higher diagnostic yield with the DSOCP than with the FSOCP (78% vs. 37%, respectively, *p*=0.004) \[[@b39-ce-2019-011]\].

To date, there is a lack of uniformity as well as a poor inter-observer agreement among experts for interpreting the visual impression of biliary strictures. Moreover, in some instances, such as benign extrinsic compression and irregular biliary mucosal pattern in primary sclerosing cholangitis, visual impression can be misleading and may result in false-positive malignant diagnoses \[[@b12-ce-2019-011],[@b40-ce-2019-011]\].

CHOLANGIOSCOPY-GUIDED BIOPSY
============================

Several studies have evaluated the diagnostic yield of DPCS-guided biopsy for indeterminate biliary strictures ([Table 5](#t5-ce-2019-011){ref-type="table"}) \[[@b14-ce-2019-011]-[@b17-ce-2019-011],[@b41-ce-2019-011]\]. In the report by Mounzer et al. on the diagnostic yield of DPCS-guided biopsy for malignant biliary strictures (96 patients), the sensitivity and specificity were 43% and 97%, respectively \[[@b14-ce-2019-011]\]. [Table 6](#t6-ce-2019-011){ref-type="table"} summarizes the performance of SOCP-guided biopsy in diagnosing malignant biliary strictures \[[@b18-ce-2019-011]-[@b34-ce-2019-011]\]. The reported sensitivity, specificity, and accuracy of this technique were 49% to 100%, 82% to 100% and 55% to 100%, respectively ([Table 7](#t7-ce-2019-011){ref-type="table"}) \[[@b6-ce-2019-011],[@b9-ce-2019-011],[@b14-ce-2019-011],[@b35-ce-2019-011]-[@b37-ce-2019-011]\]. In a multicenter study (140 patients from 15 centers) on the diagnostic yield of FSOCP-guided biopsy, the sensitivity and specificity for diagnosing malignant biliary strictures were 49% and 98%, respectively. This study also reported a higher sensitivity for intrinsic lesions than for extrinsic lesions (66% vs. 8%, respectively). This difference highlights an important limitation of cholangioscopy biopsy forceps, i.e., inability to reach extrinsic lesions for tissue sampling in a significant number of patients \[[@b19-ce-2019-011]\]. In a systematic review on the diagnostic yield of FSOCP-guided biopsy for malignant biliary strictures, the pooled sensitivity and specificity were 60% and 98%, respectively \[[@b38-ce-2019-011]\].

The first study on the diagnostic yield of DSOCP-guided biopsy for malignant biliary strictures (two centers; 44 patients) reported a sensitivity and specificity of 85% and 100%, respectively \[[@b34-ce-2019-011]\]. Another similar study (six centers; 250 procedures) reported a sensitivity and specificity of 57% and 100%, respectively \[[@b26-ce-2019-011]\].

Limited data suggest that the diagnostic yield of cholangioscopy-guided biopsy may be improved by rapid on-site evaluation using a method of touch imprint cytology, with reported sensitivity and accuracy of 100% and 93.5%, respectively, for diagnosing malignant biliary strictures \[[@b35-ce-2019-011]\]. However, more studies are needed to illustrate the cost-effectiveness of this approach further.

SAFETY AND ADVERSE EVENTS
=========================

[Table 8](#t8-ce-2019-011){ref-type="table"} summarizes the available data on overall cholangioscopy-related adverse events (AEs) \[[@b14-ce-2019-011]-[@b16-ce-2019-011],[@b18-ce-2019-011]-[@b27-ce-2019-011],[@b29-ce-2019-011]-[@b34-ce-2019-011],[@b42-ce-2019-011]\]. The overall AE rate of the SOCP for both diagnostic and therapeutic procedures was between 2% and 30%. The AEs included cholangitis, pancreatitis, hemobilia, bile leak, and rare and serious AEs, such as air embolization and bile duct perforation. Sethi et al. compared the AE rate between 402 patients who underwent ERCP with cholangioscopy and 3,475 patients who underwent ERCP only and reported a higher overall AE rate in the former group of patients (7% vs. 2.9%, respectively; odds ratio \[OR\], 2.5; 95% confidence interval \[CI\], 1.56--3.89) \[[@b43-ce-2019-011]\]. Their subgroup analysis also revealed a higher rate of cholangitis in the former group (1.0% vs. 0.2%, respectively, OR, 4.95; 95% CI, 1.06--19.67), with similar rates of pancreatitis and perforation \[[@b43-ce-2019-011]\]. In a systematic review including 49 studies on the SOCP and DPCS, the overall and severe AE rates were 7% and 1%, respectively, with cholangitis being the most common AE (4%) \[[@b44-ce-2019-011]\]. Turowski et al. reported an AE rate of 13.2% in 250 patients who underwent surgery using the DSOCP, with cholangitis being the most common AE (8%) \[[@b26-ce-2019-011]\]. Prophylactic pre-procedural antibiotics were administered in 40% (102) of the patients, which resulted in a significantly lower rate of cholangitis in comparison with those who did not receive antibiotic prophylaxis (*n*=148, 60%) (1% vs. 12.8%, *p*\<0.01). Therefore, administration of peri-procedural antibiotics should be recommended in all patients undergoing cholangioscopy \[[@b26-ce-2019-011]\]. The recent retrospective multicenter study (three centers; 341 patients) by Bernica et al. compared cholangioscopy-related AEs among 209 patients divided into three different age groups (178 patients aged \<65 years; 86 patients aged 65-75 years; and 77 patients aged \>75 years) \[[@b45-ce-2019-011]\]. The overall AE rate was 7.3%, with no significant difference among the three age groups (7.30% for the patients aged \<65 years, 6.98% for those aged 65--75 years, and 7.79% for those aged \>75 years; *p*\<0.17) \[[@b45-ce-2019-011]\].

Air embolism is a rare but serious AE of the DPCS and has been reported in 0%--2.3% of procedures. The use of water for better visualization and CO~2~ instead of air for insufflation is recommended to minimize this fatal AE \[[@b46-ce-2019-011]\].

COST
====

There are limited data on the economic impact of the use of cholangioscopy compared with other conventional modalities. Recently, Deprez et al. compared the use of ERCP and the SOCP for the diagnosis of malignant biliary strictures and reported that the use of the SOCP reduces the number of needed procedures by 31% and saves approximately 5% of the allocated budget \[[@b47-ce-2019-011]\]. Further studies are needed to evaluate the cost-effectiveness of the SOCP in other clinical settings.

CONCLUSIONS
===========

The evaluation of indeterminate biliary strictures presents a diagnostic challenge, and early precise diagnosis is important for achieving optimal patient outcomes and avoiding unnecessary surgical procedures. Radiologic evaluation is useful to detect and characterize strictures and select the best endoscopic diagnostic technique. In patients with biliary strictures due to extrinsic compression (e.g., pancreatic tumors or regional lymphadenopathy) and those with distal biliary lesions, EUS-FNA should be considered as the first endoscopic procedure. If EUS-FNA reveals no diagnostic findings, ERCP with cholangioscopy should be performed next and possibly during the same session. The new-generation DSOCP has improved the image quality and is safe even in the geriatric population. However, the interpretation of cholangioscopic visual findings remains challenging, and to date, there is a lack of uniformity and a poor inter-observer agreement among experts for the visual interpretation of indeterminate biliary strictures. Although miniature biopsy forceps are essential in the sampling of indeterminate strictures, the yield is suboptimal in certain patients. Studies focusing on the optimization of biopsy techniques and handling of procured specimens are needed.
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###### 

Comparison between the Two Cholangioscopy Systems

  Cholangioscopy system                                                                                                                           SpyGlass DS                                                                                                                                                                      Ultraslim endoscope
  ----------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------
  Technology                                                                                                                                      LED light source/120 degrees of digital field of view                                                                                                                            High-resolution video-scope
  Outer diameter (mm)                                                                                                                             3.5                                                                                                                                                                              4.9--5.9
  Channel diameter (mm)                                                                                                                           1.2                                                                                                                                                                              2.0
  Working length (cm)                                                                                                                             214                                                                                                                                                                              110--130
  Accessories                                                                                                                                     -SpyBite biopsy forceps                                                                                                                                                          -5-French instruments
  -Lithotripsy devices: electrohydraulic lithotripsy and laser lithotripsy                                                                        -Larger biopsy forceps                                                                                                                                                           
  -Argon plasma coagulation probes and lithotripsy fibers                                                                                                                                                                                                                                                                          
  Tip deflection                                                                                                                                  Four ways: up-down, left-right                                                                                                                                                   Four ways: up-down, left-right
  Image quality                                                                                                                                   Excellent                                                                                                                                                                        Greater than that in the DSOCP
  Advantages                                                                                                                                      -Easier access to the pancreatobiliary duct compared with the DPCS                                                                                                               -Markedly greater image quality compared with that in the DSOCP
  -Separate irrigation channel                                                                                                                    -Allows NBI and improves visualization of lesion margins and vessels                                                                                                             
  -Tip maneuverability                                                                                                                            -Larger working channel (enables several interventions with the use of 5-French diagnostic and therapeutic devices, such as photodynamic therapy and argon plasma coagulation)   
  -Redesigned working channel for passing accessories                                                                                                                                                                                                                                                                              
  -Fixed imager for consistent steering                                                                                                           -Allows simultaneous irrigation and therapy                                                                                                                                      
  -Single-use digital scope                                                                                                                                                                                                                                                                                                        
  -Simplified 5-minute setup                                                                                                                                                                                                                                                                                                       
  Disadvantages                                                                                                                                   -Expensive                                                                                                                                                                       -Large outer diameter necessitates prior sphincterotomy
  -Narrow working channel diameter                                                                                                                -More challenging procedure, requires highly skilled endoscopists                                                                                                                
  -Difficult to perform biliary cannulation owing to easy loop formation during insertion and trouble fixing the scope inside the biliary tract                                                                                                                                                                                    
  -Can only be performed in dilated bile ducts                                                                                                                                                                                                                                                                                     

DPCS, direct peroral cholangioscopy system; DSOCP, digital single-operator cholangiopancreatoscope; LED, light-emitting diode; NBI, narrow band imaging.

###### 

Cholangioscopy Indications and Contraindications

  Diagnostic indications                                                                                                                         Therapeutic indications                                             Contraindications
  ---------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------- ----------------------------------------------------------------
  Direct visualization of the biliary epithelium                                                                                                 Electrohydraulic/intra-ductal laser lithotripsy of complex stones   General contraindications to ERCP, including acute cholangitis
  Targeted biopsy of biliary strictures initially or after non-diagnostic ERCP                                                                   Endoscopic tumor ablation therapy                                   Small duct, \<5 mm in diameter
  Preoperative assessment of main-duct IPMNs and differentiation of chronic pancreatitis from main-duct IPMN in the appropriately dilated duct   Removal of proximally migrated stents                               Uncorrected coagulopathy
  Post-liver transplant biliary complications                                                                                                    Guiding treatment margins for biliary radiofrequency ablation       
  Evaluation of hemobilia                                                                                                                        Assistance with selective guidewire placement                       
  Assessment of strictures in patients with primary sclerosing cholangitis                                                                       Alternative to surgery in patients with Mirizzi type 2              
  Characterization of intra-ductal filling defects found on MRCP and ERCP                                                                        Stent placement in the cystic duct                                  
  Assessment of the etiology of recurrent unexplained choledocholithiasis                                                                        Photodynamic therapy of cholangiocarcinoma                          
                                                                                                                                                 Photocoagulation with argon in cases of IPMN                        

ERCP, endoscopic retrograde cholangiopancreatography; IPMN, intraductal papillary mucinous neoplasm; MRCP, magnetic resonance cholangiopancreatography.

###### 

Differential Diagnosis for Indeterminate Biliary Strictures

  Malignant causes                    Benign causes
  ----------------------------------- -------------------------------------
  Cholangiocarcinoma                  Chronic pancreatitis
  Pancreatic adenocarcinoma           Autoimmune diseases:
   - IgG4-associated cholangitis      
   - Sarcoidosis                      
   - Mast cell cholangitis            
  Ampullary adenocarcinoma            Cholelithiasis
  Gallbladder cancer                  Iatrogenic injury to the bile duct:
   - Cholecystectomy                  
   - Liver transplantation            
  Hepatocellular carcinoma            Infectious diseases:
   - HIV-associated disease           
   - Parasitic cholangiopathy         
   - Tuberculosis                     
  Metastatic cancer                   Vascular-related diseases:
   - Ischemic cholangiopathy          
   - Vasculitis                       
   - Intra-arterial chemotherapy      
   - Portal hypertensive biliopathy   
  Lymphoma                            

###### 

Cholangioscopy Visual Impression of Benign and Malignant Lesions

  Malignant features                           Benign features
  -------------------------------------------- ------------------------------
  Tortuous dilated vessels ("tumor vessels")   Ulceration
  Infiltrative stricture                       Atrophy
  Polypoid mass                                Concentric stenosis
  Vegetative mass                              Low-papillary mucosal lesion
  Fish-egg lesion                              Band-like scarring
  Finger-like villiform lesion                 Erythema
  Irregularly papillary or granular lesions    Pseudo-diverticulae
  Nodular elevated lesions                     
  Friability and easily bleeding               

###### 

Studies on the Diagnostic Yield of Direct Peroral Cholangioscopy System-Guided Visual Impression and Biopsy

  Study                                                                                        Study design                 Patients (*n*)   Technical success (%)   Visual sensitivity (%)   Visual specificity (%)   Visual accuracy (%)   Biopsy sensitivity (%)   Biopsy specificity (%)   Biopsy accuracy (%)
  -------------------------------------------------------------------------------------------- ---------------------------- ---------------- ----------------------- ------------------------ ------------------------ --------------------- ------------------------ ------------------------ ---------------------
  Mounzer et al. (2017) \[[@b14-ce-2019-011]\]^[a)](#tfn1-ce-2019-011){ref-type="table-fn"}^   Single-center, prospective   96               NR                      85                       84                       NR                    43                       97                       NR
  Meves et al. (2014) \[[@b15-ce-2019-011]\]                                                   Single-center, prospective   84               87                      NR                       NR                       NR                    89.5                     NR                       NR
  Farnik et al. (2014) \[[@b16-ce-2019-011]\]                                                  Multicenter, retrospective   89               88.5                    NR                       NR                       NR                    NR                       NR                       NR

NR, not reported.

In this study, 14 out of 96 patients were examined for pancreatic disease.

###### 

Single-Operator Cholangiopancreatoscope Visual Impression and SpyBite Biopsy Diagnostic Yield for Indeterminate Biliary Strictures

  Study                                              Study design                   Cholangioscopy system   Patients (*n*)   Technical success (%)                                     Visual sensitivity (%)   Visual specificity (%)   Visual accuracy (%)   Biopsy sensitivity (%)                             Biopsy specificity (%)   Biopsy accuracy (%)
  -------------------------------------------------- ------------------------------ ----------------------- ---------------- --------------------------------------------------------- ------------------------ ------------------------ --------------------- -------------------------------------------------- ------------------------ ---------------------
  Chen et al. (2007) \[[@b18-ce-2019-011]\]          Multicenter, prospective       FSOCP                   22               91                                                        100                      77                       85                    71                                                 100                      90
  Chen et al. (2011) \[[@b19-ce-2019-011]\]          Multicenter, prospective       FSOCP                   226              93 and 86^[a)](#tfn2-ce-2019-011){ref-type="table-fn"}^   78                       82                       80                    49^[b)](#tfn3-ce-2019-011){ref-type="table-fn"}^   98                       75
  Ramchandani et al. (2011) \[[@b27-ce-2019-011]\]   Single-center, prospective     FSOCP                   36               100                                                       95                       79                       89                    82                                                 82                       82
  Hartman et al. (2012) \[[@b28-ce-2019-011]\]       Single-center, retrospective   FSOCP                   89               NR                                                        88                       86                       87                    57                                                 100                      78
  Draganov et al. (2012) \[[@b29-ce-2019-011]\]      Single-center, prospective     FSOCP                   44               97.7                                                      NR                       NR                       NR                    76                                                 100                      84
  Manta et al. (2013) \[[@b30-ce-2019-011]\]         Single-center, prospective     FSOCP                   52               100                                                       NR                       NR                       NR                    88                                                 94                       90
  Woo et al. (2014) \[[@b31-ce-2019-011]\]           Single-center, retrospective   FSOCP                   32               96                                                        100                      90                       96                    64                                                 100                      73
  Tieu et al. (2015) \[[@b32-ce-2019-011]\]          Single-center, retrospective   FSOCP                   39               92.3                                                      NR                       NR                       97                    NR                                                 NR                       72
  Kurihara et al. (2016) \[[@b33-ce-2019-011]\]      Multicenter, prospective       FSOCP                   89               95.5                                                      94                       92                       94                    65                                                 89                       70
  Navaneethan et al. (2016) \[[@b34-ce-2019-011]\]   Multicenter, prospective       DSOCP                   44               100                                                       90                       96                       NR                    85                                                 100                      NR
  Laleman et al. (2017) \[[@b20-ce-2019-011]\]       Single-center, prospective     FSOCP                   45               88.9                                                      83                       83                       83                    85                                                 100                      95
  Ogura et al. (2017) \[[@b21-ce-2019-011]\]         Single-center, prospective     DSOCP                   25               100                                                       83                       89                       93                    80                                                 100                      89
  Imanishi et al. (2017) \[[@b22-ce-2019-011]\]      Single-center, retrospective   DSOCP                   20               100                                                       NR                       NR                       NR                    NR                                                 NR                       100
  Shah et al. (2017) \[[@b23-ce-2019-011]\]          Multicenter, prospective       DSOCP                   58               100                                                       97                       93                       94                    86                                                 100                      91
  Pereira et al. (2018) \[[@b24-ce-2019-011]\]       Single-center, retrospective   DSOCP                   12               100                                                       NR                       NR                       87.5                  NR                                                 NR                       55
  Lenze et al. (2018) \[[@b25-ce-2019-011]\]         Single-center, retrospective   DSOCP                   41               98.5                                                      88.9                     97.6                     NR                    62.5                                               90                       NR
  Turowski et al. (2018) \[[@b26-ce-2019-011]\]      Multicenter, retrospective     DSOCP                   99               NR                                                        95.5                     94.5                     NR                    57.7                                               100                      NR

DSOCP, digital single-operator cholangiopancreatoscope; FSOCP, fibro-optic single-operator cholangiopancreatoscope; NR, not reported.

Diagnostic FSOCP was performed without biopsy in 86 cases and with biopsy in 140 cases. The respective procedure success rates in those two groups were 93% and 86%.

The authors suggested that this low number may have been attributed to the inclusion of strictures caused by extrinsic compression.

###### 

Diagnostic Yield of the Different Available Methods for Evaluating Biliary Strictures

  Diagnostic method                              Sensitivity (%)                                       Specificity (%)   Accuracy (%)
  ---------------------------------------------- ----------------------------------------------------- ----------------- --------------
  ERCP with brushing cytology                    23-62.5                                               26-100            31-81.3
  ERCP with standard forceps biopsy              43-91                                                 97-100            30-93
  Combined ERCP with brush cytology and biopsy   60-70                                                 100               50
  ERCP plus FISH                                 30-79                                                 91-100            72-80
  EUS-FNA                                        43-86^[a)](#tfn4-ce-2019-011){ref-type="table-fn"}^   97                
  SOCP visual impression                         78-100                                                78-97.6           80-97
  SOCP SpyBite biopsy                            49-100                                                82-100            55-100
  SpyGlass with ROSE                             100                                                                     93
  DPCS visual impression                         83-92                                                 84-92             
  DPCS biopsy                                    43-89.5                                               97                
  Combined DPCS visual impression plus biopsy    85                                                    84                

DPCS, direct peroral cholangiopancreatoscopy system; ERCP, endoscopic retrograde cholangiopancreatography; EUS-FNA, endoscopic ultrasound-guided fine needle aspiration; FISH, fluorescence in situ hybridization; ROSE, rapid on-site evaluation; SOCP, single-operator cholangiopancreatoscope.

Depending on the proximal or distal strictures.

###### 

Studies with Reported Adverse Events for the Different Cholangioscopy Systems^[a)](#tfn5-ce-2019-011){ref-type="table-fn"}^

  Study                                                                                     Cholangioscopy system   Sample size (*n*)   Overall adverse events (%)   Most common adverse event (%)                        Severe adverse events (%)
  ----------------------------------------------------------------------------------------- ----------------------- ------------------- ---------------------------- ---------------------------------------------------- ----------------------------------------------------
  Mounzer et al. (2017) \[[@b14-ce-2019-011]\]                                              DPCS                    96                  2                            Bleeding (1)                                         Perforation (1) - conservative management
  Meves et al. (2014) \[[@b15-ce-2019-011]\]                                                DPCS                    84                  12                           NR                                                   0
  Farnik et al. (2014) \[[@b16-ce-2019-011]\]                                               DPCS                    89                  7.7                          Cholangitis (1.5)                                    0
  Bleeding (1.5)                                                                                                                                                                                                          
  Chen et al. (2011) \[[@b19-ce-2019-011]\]                                                 FSOCP                   297                 7.5                          Cholangitis (3.5)                                    0
  Kurihara et al. (2016) \[[@b33-ce-2019-011]\]                                             FSOCP                   89                  5.4                          Cholangitis (2.7)                                    0
  Laleman et al. (2017) \[[@b20-ce-2019-011]\]                                              FSOCP                   84                  21.4                         Mild pancreatitis (7.1)                              0
  Ogura et al. (2017) \[[@b21-ce-2019-011]\]                                                DSOCP                   55                  6                            Cholangitis (6)                                      0
  Imanishi et al. (2017) \[[@b22-ce-2019-011]\]                                             DSOCP                   28                  4                            NR                                                   0
  Shah et al. (2017) \[[@b23-ce-2019-011]\]                                                 DSOCP                   108                 3                            NR                                                   0
  Lenze et al. (2018) \[[@b25-ce-2019-011]\]                                                DSOCP                   67                  25.4                         Abdominal pain (23.8)                                16.4^[b)](#tfn6-ce-2019-011){ref-type="table-fn"}^
  Pereira et al. (2018) \[[@b24-ce-2019-011]\]                                              DSOCP                   16                  38                           NR                                                   0
  Turowski et al. (2018) \[[@b26-ce-2019-011]\]                                             DSOCP                   250                 13.2                         Cholangitis, 1% with and 12.8% without antibiotics   Perforation (0.4) - conservative management
  Chen et al. (2007) \[[@b18-ce-2019-011]\]                                                 FSOCP                   35                  6                            NR                                                   0
  Ramchandani et al. (2011) \[[@b27-ce-2019-011]\]                                          FSOCP                   36                  8.3                          Cholangitis (5.6)                                    0
  Draganov et al. (2012) \[[@b29-ce-2019-011]\]                                             FSOCP                   26                  7.7                          NR                                                   0
  Manta et al. (2013) \[[@b30-ce-2019-011]\]                                                FSOCP                   52                  3.8                          NR                                                   0
  Woo et al. (2014) \[[@b31-ce-2019-011]\]                                                  FSOCP                   32                  9.4                          NR                                                   0
  Tieu et al. (2015) \[[@b32-ce-2019-011]\]^[c)](#tfn7-ce-2019-011){ref-type="table-fn"}^   FSOCP                   88                  15.9                         Abdominal pain (11.1)                                1.1
  Tanaka et al. (2016) \[[@b42-ce-2019-011]\]                                               DSOCP                   22                  7.7                          Cholangitis (3.8)                                    0
  Pancreatitis (3.8)                                                                                                                                                                                                      
  Navaneethan et al. (2016) \[[@b34-ce-2019-011]\]                                          DSOCP                   105                 2.9                          Cholangitis (1.9)                                    0

DPCS, direct peroral cholangiopancreatoscopy system; DSOCP, digital single-operator cholangiopancreatoscope; FSOCP, fibro-optic single-operator cholangiopancreatoscope; NR, not reported.

Numbers represent the adverse event rate for both diagnostic and therapeutic procedures and includes procedures with both biliary and pancreatic accesses.

In this study, cholangitis (7.5) and pancreatitis (8.9) were considered as severe adverse events. The high rate of pancreatitis was attributed to the lack of administration of rectal indomethacin.

All cases received pre-procedural antibiotics.
